Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Bonten, MJ"" wg kryterium: Autor


Tytuł:
Estimation of introduction and transmission rates of SARS-CoV-2 in a prospective household study.
Autorzy:
van Boven M; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Center for Complex Systems Studies (CCSS), Utrecht University, Utrecht, The Netherlands.
van Dorp CH; Department of Pathology & Cell Biology, Columbia University Irving Medical Center, New York, United States of America.
Westerhof I; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Jaddoe V; Erasmus Medical Center, Rotterdam, the Netherlands.
Heuvelman V; Erasmus Medical Center, Rotterdam, the Netherlands.
Duijts L; Erasmus Medical Center, Rotterdam, the Netherlands.
Fourie E; Spaarne Gasthuis, Hoofddorp, the Netherlands.
Sluiter-Post J; Spaarne Gasthuis, Hoofddorp, the Netherlands.
van Houten MA; Spaarne Gasthuis, Hoofddorp, the Netherlands.
Badoux P; Regional Public Health Laboratory Kennemerland, Haarlem, the Netherlands.
Euser S; Regional Public Health Laboratory Kennemerland, Haarlem, the Netherlands.
Herpers B; Regional Public Health Laboratory Kennemerland, Haarlem, the Netherlands.
Eggink D; National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
de Hoog M; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Boom T; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Wildenbeest J; Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's hospital, University Medical Center Utrecht, the Netherlands.
Bont L; Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's hospital, University Medical Center Utrecht, the Netherlands.
Rozhnova G; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Center for Complex Systems Studies (CCSS), Utrecht University, Utrecht, The Netherlands.; BioISI-Biosystems & Integrative Sciences Institute, Faculdade de Ciências, Universidade de Lisboa, Lisbon, Portugal.
Bonten MJ; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Kretzschmar ME; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Center for Complex Systems Studies (CCSS), Utrecht University, Utrecht, The Netherlands.
Bruijning-Verhagen P; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Pokaż więcej
Źródło:
PLoS computational biology [PLoS Comput Biol] 2024 Jan 29; Vol. 20 (1), pp. e1011832. Date of Electronic Publication: 2024 Jan 29 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
Epidemics*
Adult ; Adolescent ; Humans ; SARS-CoV-2 ; Prospective Studies ; Family Characteristics
Czasopismo naukowe
Tytuł:
Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA).
Autorzy:
Pérez-Galera S; Unidad de Enfermedades y Microbiología, Hospital Universitario Virgen Macarena and Departamento de Medicina, Universidad de Sevilla/Instituto de Biomedicina de Sevilla/CSIC, Seville, Spain.; Servicio de Medicina Interna, Hospital Universitario Virgen Macarena, Seville, Spain.
Bravo-Ferrer JM; Unidad de Enfermedades y Microbiología, Hospital Universitario Virgen Macarena and Departamento de Medicina, Universidad de Sevilla/Instituto de Biomedicina de Sevilla/CSIC, Seville, Spain.
Paniagua M; Unidad de Enfermedades y Microbiología, Hospital Universitario Virgen Macarena and Departamento de Medicina, Universidad de Sevilla/Instituto de Biomedicina de Sevilla/CSIC, Seville, Spain.
Kostyanev T; Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.; Laboratoire National de Santé, Luxembourg, Luxembourg.
de Kraker MEA; Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
Feifel J; Institute of Statistics, Ulm University, Ulm, Germany.
Sojo-Dorado J; Unidad de Enfermedades y Microbiología, Hospital Universitario Virgen Macarena and Departamento de Medicina, Universidad de Sevilla/Instituto de Biomedicina de Sevilla/CSIC, Seville, Spain.
Schotsman J; Department of Medical Microbiology and Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Cantón R; Servicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
Daikos GL; Laiko General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Carevic B; Department of Hospital Epidemiology, Clinical Center of Serbia, Belgrade, Serbia.
Dragovac G; Faculty of Medicine and Institute of Public Health of Vojvodina, University of Novi Sad, Novi Sad, Serbia.
Tan LK; GSK, Brentford, UK.
Raka L; University of Prishtina 'Hasan Prishtina' and National Institute of Public Health of Kosovo, Prishtina, Kosovo.
Hristea A; University of Medicine and Pharmacy 'Carol Davila', Bucharest, Romania.
Viale P; Malattie Infettive, Policlinico Sant'Orsola, Bologna, Italy.
Akova M; Department of Infectious Diseases and Clinical Microbiology, Hacettepe University Faculty of Medicine, Sihhiye, Ankara, Turkey.
Reguera JM; Servicio de Enfermedades Infecciosas, Hospital Regional Universitario de Málaga, Ibima, Málaga, Spain.
Valiente de Santis L; Servicio de Enfermedades Infecciosas, Hospital Regional Universitario de Málaga, Ibima, Málaga, Spain.
Torre-Cisneros J; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Servicio de Enfermedades Infecciosas Hospital Universitario Reina Sofía/Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)/Universidad de Córdoba (Departamento de Ciencias Médicas y Quirúrgicas), Córdoba, Spain.
Cano Á; Servicio de Enfermedades Infecciosas Hospital Universitario Reina Sofía/Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)/Universidad de Córdoba (Departamento de Ciencias Médicas y Quirúrgicas), Córdoba, Spain.
Roilides E; Hippokration General Hospital of Thessaloniki, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Radulovic L; Zvezdara University Medical Center, Belgrade, Serbia.
Kirakli C; Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Izmir, Turkey.
Shaw E; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Department of Infectious Diseases, Hospital Universitari de Bellvitge, Institut d'Investigacions Biomèdiques de Bellvitge/IDIBELL, Barcelona, Spain.
Falagas ME; Henry Dunant Hospital Center, Athens, Greece.; Metropolitan General Hospital, Athens, Greece.
Pintado V; Servicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
Goossens H; Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
Bonten MJ; Institute of Statistics, Ulm University, Ulm, Germany.
Gutiérrez-Gutiérrez B; Unidad de Enfermedades y Microbiología, Hospital Universitario Virgen Macarena and Departamento de Medicina, Universidad de Sevilla/Instituto de Biomedicina de Sevilla/CSIC, Seville, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
Rodriguez-Baño J; Unidad de Enfermedades y Microbiología, Hospital Universitario Virgen Macarena and Departamento de Medicina, Universidad de Sevilla/Instituto de Biomedicina de Sevilla/CSIC, Seville, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
Pokaż więcej
Corporate Authors:
COMBACTE-CARE-EURECA Team
Źródło:
EClinicalMedicine [EClinicalMedicine] 2023 Feb 27; Vol. 57, pp. 101871. Date of Electronic Publication: 2023 Feb 27 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
PROPHETIC EU: Prospective Identification of Pneumonia in Hospitalized Patients in the Intensive Care Unit in European and United States Cohorts.
Autorzy:
Bergin SP; Duke University, Durham, North Carolina, USA.
Calvert SB; Clinical Trials Transformation Initiative, Durham, North Carolina, USA.
Farley J; US Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA.
Sun JL; Duke Clinical Research Institute, Durham, North Carolina, USA.
Chiswell K; Duke Clinical Research Institute, Durham, North Carolina, USA.
Dieperink W; University Medical Center Groningen, Groningen, the Netherlands.
Kluytmans J; Amphia Hospital, Breda, the Netherlands.
Lopez-Delgado JC; Bellvitge University Hospital, Barcelona, Spain.
Leon-Lopez R; Reina Sofía University Hospital/University of Córdoba, Córdoba, Spain.
Zervos MJ; Henry Ford Health System, Detroit, Michigan, USA.
Kollef MH; Washington University School of Medicine, St Louis, Missouri, USA.
Sims M; Beaumont Health System, Royal Oak, Michigan, USA.
Kabchi BA; East Carolina University, Greenville, North Carolina, USA.
Rubin D; US Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA.
Santiago J; US Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA.
Natarajan M; US Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA.
Tenaerts P; Clinical Trials Transformation Initiative, Durham, North Carolina, USA.
Fowler VG; Duke University, Durham, North Carolina, USA.
Holland TL; Duke University, Durham, North Carolina, USA.
Bonten MJ; University Medical Center Utrecht, Utrecht, the Netherlands.
Hullegie SJ; University Medical Center Utrecht, Utrecht, the Netherlands.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2022 May 09; Vol. 9 (7), pp. ofac231. Date of Electronic Publication: 2022 May 09 (Print Publication: 2022).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Source-specific host response and outcomes in critically ill patients with sepsis: a prospective cohort study.
Autorzy:
Peters-Sengers H; Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam, Room T1.240, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. .; The Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Centers, Amsterdam, The Netherlands. .
Butler JM; Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam, Room T1.240, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.; The Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
Uhel F; Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam, Room T1.240, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.; The Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
Schultz MJ; Department of Intensive Care Medicine, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Laboratory of Experimental Intensive Care and Anesthesiology (L.E.I.C.A), Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Mahidol-Oxford Tropical Medicine Research Unit (MORU), Mahidol University, Bangkok, Thailand.; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Bonten MJ; Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands.; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Cremer OL; Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
Scicluna BP; Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam, Room T1.240, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.; The Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Centers, Amsterdam, The Netherlands.; Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
van Vught LA; Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam, Room T1.240, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.; The Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
van der Poll T; Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam, Room T1.240, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.; The Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Centers, Amsterdam, The Netherlands.; Division of Infectious Diseases, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Pokaż więcej
Corporate Authors:
MARS consortium
Źródło:
Intensive care medicine [Intensive Care Med] 2022 Jan; Vol. 48 (1), pp. 92-102. Date of Electronic Publication: 2021 Dec 13.
Typ publikacji:
Journal Article
MeSH Terms:
Critical Illness*
Sepsis*
Biomarkers ; Cohort Studies ; Humans ; Intensive Care Units ; Prospective Studies
Czasopismo naukowe
Tytuł:
Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial.
Autorzy:
François B; ICU Department, Inserm CIC-1435 and UMR-1092, CRICS-TRIGGERSEP Network, CHU Dupuytren, Limoges, France. Electronic address: .
Jafri HS; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA. Electronic address: .
Chastre J; Institut de Cardiologie, Service de Réanimation Médicale, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
Sánchez-García M; Department of Critical Care, Hospital Clínico San Carlos, Madrid, Spain.
Eggimann P; Department of Critical Care, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Dequin PF; CHRU de Tours, Service de Médecine Intensive Réanimation, Inserm CIC 1415 and UMR-1100, and CRICS-TRIGGERSEP Network, Tours, France.
Huberlant V; Centre Hospitalier Jolimont-Lobbes, La Louvière, Belgium.
Viña Soria L; Hospital Universitario Central de Asturias, Asturias, Spain.
Boulain T; Centre Hospitalier Régional d'Orléans, Médecine Intensive Réanimation, Orleans, France.
Bretonnière C; Service de Soins Intensifs-Pneumologie, Hôpital Guillaume et René Laennec, Nantes, France.
Pugin J; Département d'Anesthésiologie, Pharmacologie, Soins Intensifs et Urgences, Université de Genève, Geneva, Switzerland.
Trenado J; Intensive Care Department, Hospital Universitari Mutua de Terrassa, Terrassa, Spain.
Hernandez Padilla AC; CHU Limoges and Inserm UMR-1092, Limoges, France.
Ali O; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Shoemaker K; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Ren P; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Coenjaerts FE; Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, Netherlands.
Ruzin A; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Barraud O; CHU Limoges and Inserm UMR-1092, Limoges, France.
Timbermont L; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, Antwerp University Hospital, Antwerp, Belgium.
Lammens C; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, Antwerp University Hospital, Antwerp, Belgium.
Pierre V; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Wu Y; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Vignaud J; CHU Limoges and Inserm UMR-1092, Limoges, France.
Colbert S; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Bellamy T; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Esser MT; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Dubovsky F; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Bonten MJ; Department of Medical Microbiology and Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands.
Goossens H; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, Antwerp University Hospital, Antwerp, Belgium.
Laterre PF; Intensive Care Unit, Université Catholique de Louvain, Louvain-la-Neuve, Belgium.
Pokaż więcej
Corporate Authors:
COMBACTE Consortium and the SAATELLITE Study Group
Źródło:
The Lancet. Infectious diseases [Lancet Infect Dis] 2021 Sep; Vol. 21 (9), pp. 1313-1323. Date of Electronic Publication: 2021 Apr 21.
Typ publikacji:
Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies, Monoclonal, Humanized/*therapeutic use
Broadly Neutralizing Antibodies/*therapeutic use
Pneumonia, Ventilator-Associated/*prevention & control
Staphylococcal Infections/*prevention & control
Staphylococcus aureus/*drug effects
Adolescent ; Adult ; Aged ; Antibodies, Monoclonal, Humanized/administration & dosage ; Belgium ; Broadly Neutralizing Antibodies/administration & dosage ; Czech Republic ; Double-Blind Method ; Female ; France ; Germany ; Greece ; Humans ; Hungary ; Lung ; Male ; Middle Aged ; Pilot Projects ; Portugal ; Respiration, Artificial ; Spain ; Switzerland ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł:
Do we need to change catheter-related bloodstream infection surveillance in the Netherlands? A qualitative study among infection prevention professionals.
Autorzy:
Verberk JD; Medical Microbiology and Infection Control, UMC Utrecht, Utrecht, The Netherlands .; Epidemiology and Surveillance, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
van der Kooi TI; Epidemiology and Surveillance, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Derde LP; Department of Intensive Care Medicine, UMC Utrecht, Utrecht, The Netherlands.
Bonten MJ; Department of Medical Microbiology, UMC Utrecht, Utrecht, The Netherlands.
de Greeff SC; Epidemiology and Surveillance, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
van Mourik MS; Medical Microbiology and Infection Control, UMC Utrecht, Utrecht, The Netherlands.
Pokaż więcej
Źródło:
BMJ open [BMJ Open] 2021 Aug 18; Vol. 11 (8), pp. e046366. Date of Electronic Publication: 2021 Aug 18.
Typ publikacji:
Journal Article
MeSH Terms:
Catheter-Related Infections*/epidemiology
Catheter-Related Infections*/prevention & control
Sepsis*
Catheters ; Humans ; Netherlands/epidemiology ; Reproducibility of Results
Czasopismo naukowe
Tytuł:
The circulatory small non-coding RNA landscape in community-acquired pneumonia on intensive care unit admission.
Autorzy:
Khan HN; Center for Experimental Molecular Medicine, Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, The Netherlands.; Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam University Medical Centers, location Academic Medical Center, Amsterdam, The Netherlands.
Jongejan A; Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam University Medical Centers, location Academic Medical Center, Amsterdam, The Netherlands.
van Vught LA; Center for Experimental Molecular Medicine, Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, The Netherlands.
Horn J; Department of Intensive Care & Laboratory of Experimental Intensive Care and Anesthesiology (L·E·I·C·A), Amsterdam University Medical Centers, location Academic Medical Center, Amsterdam, The Netherlands.
Schultz MJ; Department of Intensive Care & Laboratory of Experimental Intensive Care and Anesthesiology (L·E·I·C·A), Amsterdam University Medical Centers, location Academic Medical Center, Amsterdam, The Netherlands.; Mahidol-Oxford Tropical Medicine Research Unit (MORU), Mahidol University, Bangkok, Thailand.
Zwinderman AH; Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam University Medical Centers, location Academic Medical Center, Amsterdam, The Netherlands.
Cremer OL; Department of Intensive Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Bonten MJ; Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands.; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
van der Poll T; Center for Experimental Molecular Medicine, Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, The Netherlands.; Division of Infectious Diseases, Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Scicluna BP; Center for Experimental Molecular Medicine, Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, The Netherlands.; Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam University Medical Centers, location Academic Medical Center, Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
Journal of cellular and molecular medicine [J Cell Mol Med] 2021 Aug; Vol. 25 (16), pp. 7621-7630. Date of Electronic Publication: 2021 Jul 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Community-Acquired Infections/*pathology
MicroRNAs/*genetics
Pneumococcal Infections/*pathology
Pneumonia/*pathology
RNA, Small Untranslated/*genetics
Sepsis/*pathology
Streptococcus pneumoniae/*genetics
Aged ; Community-Acquired Infections/blood ; Community-Acquired Infections/genetics ; Community-Acquired Infections/microbiology ; Female ; Humans ; Intensive Care Units/organization & administration ; Male ; MicroRNAs/blood ; Middle Aged ; Pneumococcal Infections/blood ; Pneumococcal Infections/genetics ; Pneumococcal Infections/microbiology ; Pneumonia/blood ; Pneumonia/genetics ; Pneumonia/microbiology ; RNA, Small Untranslated/blood ; Sepsis/blood ; Sepsis/genetics ; Severity of Illness Index ; Streptococcus pneumoniae/isolation & purification ; Streptococcus pneumoniae/pathogenicity
Czasopismo naukowe
Tytuł:
The leukocyte non-coding RNA landscape in critically ill patients with sepsis.
Autorzy:
Scicluna BP; Amsterdam UMC, University of Amsterdam, Center for Experimental Molecular Medicine, Amsterdam Infection & Immunity, Amsterdam, Netherlands.; Amsterdam UMC, University of Amsterdam, Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam, Netherlands.
Uhel F; Amsterdam UMC, University of Amsterdam, Center for Experimental Molecular Medicine, Amsterdam Infection & Immunity, Amsterdam, Netherlands.
van Vught LA; Amsterdam UMC, University of Amsterdam, Center for Experimental Molecular Medicine, Amsterdam Infection & Immunity, Amsterdam, Netherlands.
Wiewel MA; Amsterdam UMC, University of Amsterdam, Center for Experimental Molecular Medicine, Amsterdam Infection & Immunity, Amsterdam, Netherlands.
Hoogendijk AJ; Amsterdam UMC, University of Amsterdam, Center for Experimental Molecular Medicine, Amsterdam Infection & Immunity, Amsterdam, Netherlands.
Baessman I; Cologne Center for Genomics, University of Cologne, Cologne, Germany.
Franitza M; Cologne Center for Genomics, University of Cologne, Cologne, Germany.
Nürnberg P; Cologne Center for Genomics, University of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.
Horn J; Amsterdam UMC, University of Amsterdam, Department of Intensive Care Medicine, Amsterdam, Netherlands.
Cremer OL; Department of Intensive Care, University Medical Center Utrecht, Utrecht, Netherlands.
Bonten MJ; Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, Netherlands.; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands.
Schultz MJ; Amsterdam UMC, University of Amsterdam, Department of Intensive Care Medicine, Amsterdam, Netherlands.
van der Poll T; Amsterdam UMC, University of Amsterdam, Center for Experimental Molecular Medicine, Amsterdam Infection & Immunity, Amsterdam, Netherlands.; Amsterdam UMC, University of Amsterdam, Division of Infectious Diseases, Amsterdam, Netherlands.
Pokaż więcej
Corporate Authors:
Molecular Diagnosis and Risk Stratification in Sepsis (MARS) consortium
Źródło:
ELife [Elife] 2020 Dec 11; Vol. 9. Date of Electronic Publication: 2020 Dec 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Critical Illness*
Leukocytes/*metabolism
RNA, Untranslated/*metabolism
Sepsis/*metabolism
Aged ; Case-Control Studies ; Endotoxemia/metabolism ; Female ; Humans ; Male ; Middle Aged ; Oligonucleotide Array Sequence Analysis ; Transcriptome
Czasopismo naukowe
Tytuł:
Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration.
Autorzy:
Tritschler T; Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.; Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Mathieu ME; Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
Skeith L; Department of Medicine, University of Calgary, Calgary, AB, Canada.
Rodger M; Department of Medicine, McGill University, Montreal, QC, Canada.
Middeldorp S; Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Brighton T; Department of Haematology, New South Wales Health Pathology Randwick, Prince of Wales Hospital, Sydney, NSW, Australia.
Sandset PM; Department of Haematology, Oslo University Hospital and University of Oslo, Oslo, Norway.
Kahn SR; Department of Medicine, McGill University, Montreal, QC, Canada.; Divisions of Internal Medicine and Clinical Epidemiology, Jewish General Hospital/Lady Davis Institute, Montreal, QC, Canada.
Angus DC; University of Pittsburgh and UPMC Health System, Pittsburgh, PA, USA.
Blondon M; Division of Angiology and Haemostasis, Faculty of Medicine and Geneva University Hospitals, Geneva, Switzerland.
Bonten MJ; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.
Cattaneo M; Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milan, Italy.
Cushman M; Departments of Medicine and Pathology & Laboratory Medicine, Larner College of Medicine at the University of Vermont, Burlington, VT, USA.
Derde LPG; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.; Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
DeSancho MT; Division of Hematology-Oncology, Department of Medicine, Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY, USA.
Diehl JL; Service de Médecine Intensive - Réanimation, Hôpital Européen Georges Pompidou, Assistance Publique - Hôpitaux de Paris, Paris, France.; Innovative Therapies in Haemostasis, INSERM UMR-S1140, Paris University, Paris, France.
Goligher E; Interdivisional Department of Critical Care, University of Toronto, Toronto, ON, Canada.; Division of Respirology, Department of Medicine, University Health Network, Toronto, ON, Canada.
Jilma B; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
Jüni P; Applied Health Research Centre, Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, ON, Canada.; Department of Medicine and Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada.
Lawler PR; Peter Munk Cardiac Centre, University Health Network, Toronto, ON, Canada.; Ted Rogers Centre for Heart Research, Toronto, ON, Canada.; Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada.
Marietta M; Dipartimento Oncologia ed Ematologia, Azienda Ospedaliero-Universitaria di Modena, Ospedale Policlinico, Modena, Italy.
Marshall JC; Department of Critical Care Medicine, St Michael's Hospital, Toronto, ON, Canada.
McArthur C; Auckland City Hospital, Intensive Care, Auckland, New Zealand.
Miranda CH; Division of Emergency Medicine, Department of Internal Medicine, Ribeirão Preto School of Medicine, São Paulo University, Ribeirão Preto, Brazil.
Mirault T; Innovative Therapies in Haemostasis, INSERM UMR-S1140, Paris University, Paris, France.; PARCC, INSERM U970, Paris, France.; Hôpital Européen Georges-Pompidou, Assistance Publique - Hôpitaux de Paris, Paris, France.
Morici N; Intensive Cardiac Care Unit and De Gasperis Cardio Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Perepu U; Department of Internal Medicine, University of Iowa, Iowa City, IA, USA.
Schörgenhofer C; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
Sholzberg M; St. Michael's Hospital and Departments of Medicine, and Laboratory Medicine and Pathobiology, Li Ka Shing Knowledge Institute, University of Toronto, Toronto, ON, Canada.
Spyropoulos AC; Feinstein Institutes for Medical Research and The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, and Department of Medicine, Anticoagulation and Clinical Thrombosis Services, Northwell Health at Lenox Hill Hospital, New York, NY, USA.
Webb SA; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
Zarychanski R; Department of Internal Medicine, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada.; Cancer Care Manitoba, Research Institute of Oncology and Haematology, Winnipeg, MB, Canada.
Zuily S; Vascular Medicine Division and Regional Competence Center for Marfan Syndrome, Inserm, DCAC and CHRU-Nancy, Université de Lorraine, Nancy, France.
Le Gal G; Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
Pokaż więcej
Corporate Authors:
International Network of VENous Thromboembolism Clinical Research Networks INVENT-VTE
Źródło:
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2020 Nov; Vol. 18 (11), pp. 2958-2967. Date of Electronic Publication: 2020 Oct 01.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Hospitalization*
International Cooperation*
COVID-19 Drug Treatment*
Anticoagulants/*administration & dosage
Thrombosis/*prevention & control
Venous Thromboembolism/*prevention & control
Anticoagulants/adverse effects ; COVID-19/blood ; COVID-19/diagnosis ; COVID-19/mortality ; Cooperative Behavior ; Humans ; Multicenter Studies as Topic ; Patient Selection ; Randomized Controlled Trials as Topic ; Risk Assessment ; Risk Factors ; Thrombosis/blood ; Thrombosis/diagnosis ; Thrombosis/mortality ; Treatment Outcome ; Venous Thromboembolism/blood ; Venous Thromboembolism/diagnosis ; Venous Thromboembolism/mortality
Czasopismo naukowe
Tytuł:
Mortality and host response aberrations associated with transient and persistent acute kidney injury in critically ill patients with sepsis: a prospective cohort study.
Autorzy:
Uhel F; Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, Room G2-130; Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. .
Peters-Sengers H; Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, Room G2-130; Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Falahi F; Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, Room G2-130; Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Scicluna BP; Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, Room G2-130; Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.; Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
van Vught LA; Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, Room G2-130; Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Bonten MJ; Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands.; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Cremer OL; Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
Schultz MJ; Department of Intensive Care Medicine, and Laboratory of Experimental Intensive Care and Anesthesiology (L·E·I·C·A), Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Mahidol-Oxford Tropical Medicine Research Unit (MORU), Mahidol University, Bangkok, Thailand.; Nuffield Department of medicine, University of Oxford, Oxford, UK.
van der Poll T; Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, Room G2-130; Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.; Division of Infectious Diseases, Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Pokaż więcej
Corporate Authors:
MARS consortium
Źródło:
Intensive care medicine [Intensive Care Med] 2020 Aug; Vol. 46 (8), pp. 1576-1589. Date of Electronic Publication: 2020 Jun 08.
Typ publikacji:
Journal Article
MeSH Terms:
Acute Kidney Injury*/etiology
Sepsis*/complications
Critical Illness ; Humans ; Intensive Care Units ; Netherlands/epidemiology ; Prospective Studies
Czasopismo naukowe
Tytuł:
Correction to: Two Randomized Controlled Trials of Bacillus Calmette-Guérin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials.
Autorzy:
Ten Doesschate T; University Medical Center, Utrecht, The Netherlands. .
Moorlag SJCFM; Radboud University, Medical Center, Nijmegen, the Netherlands.
van der Vaart TW; University Medical Center, Utrecht, The Netherlands.
Taks E; Radboud University, Medical Center, Nijmegen, the Netherlands.
Debisarun P; Radboud University, Medical Center, Nijmegen, the Netherlands.
Ten Oever J; Radboud University, Medical Center, Nijmegen, the Netherlands.
Bleeker-Rovers CP; Radboud University, Medical Center, Nijmegen, the Netherlands.
Verhagen PB; University Medical Center, Utrecht, The Netherlands.
Lalmohamed A; University Medical Center, Utrecht, The Netherlands.
Ter Heine R; Radboud University, Medical Center, Nijmegen, the Netherlands.
van Crevel R; Radboud University, Medical Center, Nijmegen, the Netherlands.
van de Wijgert J; University Medical Center, Utrecht, The Netherlands.
Janssen AB; University Medical Center, Utrecht, The Netherlands.
Bonten MJ; University Medical Center, Utrecht, The Netherlands.
van Werkhoven CH; University Medical Center, Utrecht, The Netherlands.
Netea MG; Radboud University, Medical Center, Nijmegen, the Netherlands.
Pokaż więcej
Corporate Authors:
BCG-CORONA study team#
Źródło:
Trials [Trials] 2020 Jun 22; Vol. 21 (1), pp. 555. Date of Electronic Publication: 2020 Jun 22.
Typ publikacji:
Journal Article; Published Erratum
Czasopismo naukowe
Tytuł:
Two Randomized Controlled Trials of Bacillus Calmette-Guérin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials.
Autorzy:
Ten Doesschate T; University Medical Center, Utrecht, The Netherlands. .
Moorlag SJCFM; Radboud University Medical Center, Nijmegen, the Netherlands.
van der Vaart TW; University Medical Center, Utrecht, The Netherlands.
Taks E; Radboud University Medical Center, Nijmegen, the Netherlands.
Debisarun P; Radboud University Medical Center, Nijmegen, the Netherlands.
Ten Oever J; Radboud University Medical Center, Nijmegen, the Netherlands.
Bleeker-Rovers CP; Radboud University Medical Center, Nijmegen, the Netherlands.
Verhagen PB; University Medical Center, Utrecht, The Netherlands.
Lalmohamed A; University Medical Center, Utrecht, The Netherlands.
Ter Heine R; Radboud University Medical Center, Nijmegen, the Netherlands.
van Crevel R; Radboud University Medical Center, Nijmegen, the Netherlands.
van de Wijgert J; University Medical Center, Utrecht, The Netherlands.
Janssen AB; University Medical Center, Utrecht, The Netherlands.
Bonten MJ; University Medical Center, Utrecht, The Netherlands.
van Werkhoven CH; University Medical Center, Utrecht, The Netherlands.
Netea MG; Radboud University Medical Center, Nijmegen, the Netherlands.
Pokaż więcej
Corporate Authors:
BCG-CORONA study team#
Źródło:
Trials [Trials] 2020 Jun 05; Vol. 21 (1), pp. 481. Date of Electronic Publication: 2020 Jun 05.
Typ publikacji:
Clinical Trial Protocol; Letter
MeSH Terms:
Absenteeism*
Betacoronavirus*
Health Personnel*
Randomized Controlled Trials as Topic*
Vaccination*
BCG Vaccine/*immunology
Coronavirus Infections/*prevention & control
Pandemics/*prevention & control
Pneumonia, Viral/*prevention & control
Adult ; Aged ; Aged, 80 and over ; COVID-19 ; Female ; Hospitalization ; Humans ; Male ; Middle Aged ; Multicenter Studies as Topic ; SARS-CoV-2
Opinia redakcyjna
Tytuł:
Contact isolation versus standard precautions to decrease acquisition of extended-spectrum β-lactamase-producing Enterobacterales in non-critical care wards: a cluster-randomised crossover trial.
Autorzy:
Maechler F; Institute of Hygiene and Environmental Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany. Electronic address: .
Schwab F; Institute of Hygiene and Environmental Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Hansen S; Institute of Hygiene and Environmental Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Fankhauser C; Infection Control Program, Geneva University Hospitals and Medical School, Geneva, Switzerland.
Harbarth S; Infection Control Program, Geneva University Hospitals and Medical School, Geneva, Switzerland.
Huttner BD; Infection Control Program, Geneva University Hospitals and Medical School, Geneva, Switzerland.
Diaz-Agero C; Servicio de Medicina Preventiva y Salud Pública, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain.
Lopez N; Servicio de Medicina Preventiva y Salud Pública, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain.
Canton R; Servicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain.
Ruiz-Garbajosa P; Servicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain.
Blok H; Department of Medical Microbiology and Infection Control, Julius Center, University Medical Center Utrecht, Utrecht, Netherlands.
Bonten MJ; Department of Medical Microbiology and Infection Control, Julius Center, University Medical Center Utrecht, Utrecht, Netherlands.
Kloosterman F; Department of Medical Microbiology and Infection Control, Julius Center, University Medical Center Utrecht, Utrecht, Netherlands.
Schotsman J; Department of Biostatistics and Research Support, Julius Center, University Medical Center Utrecht, Utrecht, Netherlands.
Cooper BS; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Behnke M; Institute of Hygiene and Environmental Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Golembus J; Institute of Hygiene and Environmental Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Kola A; Institute of Hygiene and Environmental Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Gastmeier P; Institute of Hygiene and Environmental Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Pokaż więcej
Corporate Authors:
R-GNOSIS WP5 study group
Źródło:
The Lancet. Infectious diseases [Lancet Infect Dis] 2020 May; Vol. 20 (5), pp. 575-584. Date of Electronic Publication: 2020 Feb 19.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Cross Infection/*prevention & control
Enterobacteriaceae/*metabolism
Enterobacteriaceae Infections/*prevention & control
Infection Control/*methods
beta-Lactamases/*metabolism
Adult ; Carrier State/prevention & control ; Critical Care/methods ; Cross-Over Studies ; Female ; Germany ; Hospitals ; Humans ; Male ; Netherlands ; Patient Isolation/methods ; Prevalence ; Quarantine ; Spain ; Switzerland
Czasopismo naukowe
Tytuł:
Correction to: Predicting the clinical trajectory in critically ill patients with sepsis: a cohort study.
Autorzy:
Klein Klouwenberg PMC; Department of Medical Microbiology and Immunology, Rijnstate Hospital, Wagnerlaan 55, 6815, AD, Arnhem, the Netherlands. .
Spitoni C; Department of Mathematics, University Utrecht, Utrecht, the Netherlands.
van der Poll T; Center for Experimental and Molecular Medicine, Division of Infectious Diseases, Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Bonten MJ; Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Cremer OL; Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Pokaż więcej
Corporate Authors:
MARS consortium
Źródło:
Critical care (London, England) [Crit Care] 2020 Feb 06; Vol. 24 (1), pp. 41. Date of Electronic Publication: 2020 Feb 06.
Typ publikacji:
Journal Article; Published Erratum
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies